As at May 2, 2024, the MEDP stock has a price-to-earnings ratio of 38.45. This is based on the current EPS of $10.17 and the stock price of $391.07 per share. An increase of 20% has been recorded in the PE ratio compared to the average of 32.1 of the last four quarters.
The mean historical PE ratio of Medpace Holdings over the last eight years is 42.07. The current 38.45 P/E ratio is 9% lower than the historical average. In the past eight years, MEDP's PE ratio peaked in the Sep 2016 quarter at 248.83, with a price of $29.86 and an EPS of $0.12. The Mar 2023 quarter marked the lowest point at 22.99, with a price of $188.05 and an EPS of $8.18.
Maximum annual increase: 25.76% in 2021
Maximum annual decrease: -61.8% in 2017
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 33.32 | 18.75% |
| 2022 | 28.06 | -34.76% |
| 2021 | 43.01 | 25.76% |
| 2020 | 34.2 | 13.51% |
| 2019 | 30.13 | 16.69% |
| 2018 | 25.82 | -28.79% |
| 2017 | 36.26 | -61.8% |
| 2016 | 94.92 | N/A |
| 2015 | N/A | N/A |
The current PE ratio of MEDP is higher than its 3 and 5-year historical averages.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MEDP Medpace Holdings Inc | 38.6 | $12.16B |
| OMER Omeros Corp | N/A | $216.13M |
| OMGA Omega Therapeutics Inc | N/A | $142.3M |
The price to earnings ratio for MEDP stock is 38.45 as of May 2, 2024.
As an average over the last 3 years, MEDP stock has a PE ratio of 31.05.
As an average over the last 5 years, MEDP stock has a PE ratio of 30.99.
The highest quarterly PE ratio in the last eight years has been 248.83 and it was in the Sep 2016 quarter.
MEDP's current price to earnings ratio is 9% below its 8-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (May 2, 2024), Medpace Holdings's stock price is $391.07. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $10.17. Therefore, Medpace Holdings's PE ratio for today is 38.45. PE RATIO(38.45) = STOCK PRICE($391.07) / TTM EPS($10.17)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.